Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;58(3):e122-e124.
doi: 10.1016/j.jcjo.2022.10.002. Epub 2022 Oct 23.

Multiple evanescent white dot syndrome following COVID-19 vaccines

Soumaya Bouhout  1 , Mélanie Hébert  2 , Julie Vadboncoeur  3 , Marie-Josée Aubin  4
Affiliations

Multiple evanescent white dot syndrome following COVID-19 vaccines

Soumaya Bouhout et al. Can J Ophthalmol. 2023 Jun.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Fluorescein angiography performed in case 1 showing hyperfluorescent lesions with late staining in a wreathlike configuration.
Fig 2
Fig. 2
Fundus autofluorescence showing widespread punctiform hyperautofluorescent lesions distributed in a wreathlike configuration around the macula and optic nerve.
See this image and copyright information in PMC

References

    1. Crawford CM, Igboeli O. A review of the inflammatory chorioretinopathies: the white dot syndromes. ISRN Inflamm. 2013;2013 - PMC - PubMed
    1. Conrady CD, Faia LJ, Gregg KS, Rao RC. Coronavirus-19-associated retinopathy. Ocul Immunol Inflamm. 2021;29(4):675–676. - PMC - PubMed
    1. Ng CC, Jumper JM, Cunningham ET., Jr. Multiple evanescent white dot syndrome following influenza immunization: a multimodal imaging study. Am J Ophthalmol Case Rep. 2020;19 - PMC - PubMed
    1. Xu Y, Shen W. Presumed recurrent MEWDS following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1234–1237. - PubMed
    1. Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1216–1224. - PMC - PubMed

Substances